These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4163988)

  • 1. Serum-creatine-phosphokinase levels.
    Iwashita H; Ohta Y
    Lancet; 1967 Mar; 1(7490):621. PubMed ID: 4163988
    [No Abstract]   [Full Text] [Related]  

  • 2. Creatine phosphokinase in neuromuscular disease. Patients and families.
    Goto I; Peters HA; Reese HH
    Arch Neurol; 1967 May; 16(5):529-35. PubMed ID: 6022535
    [No Abstract]   [Full Text] [Related]  

  • 3. [The behavior of serum creatine phosphokinase in myopathies].
    Iori E
    Boll Soc Ital Biol Sper; 1965 Dec; 41(23):1455-6. PubMed ID: 5878343
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Creatine phosphokinase as indicator of adenosine triphosphate activity.
    Sklar SH; Wigand JS
    JAMA; 1973 Dec; 226(12):1464-5. PubMed ID: 4800819
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute hepatitis E with elevated creatine phosphokinase.
    Kitazawa T; Ota Y; Suzuki M; Morisawa Y; Shintani Y; Koike K; Kimura S
    Intern Med; 2003 Sep; 42(9):899-902. PubMed ID: 14518686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatine phosphokinase of the blood serum in muscular disorders.
    Sercl M; Kovarík J; Tichý K; Kyral V; Lichý J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1973; 16(3):129-45. PubMed ID: 4531711
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum creatine phosphokinase and haemolysis.
    Hughes BP
    Clin Chim Acta; 1968 Aug; 21(2):287-8. PubMed ID: 5667347
    [No Abstract]   [Full Text] [Related]  

  • 8. Effective use of serum creatine phosphokinase assay.
    Engel AG
    Minn Med; 1968 Mar; 51(3):371-3. PubMed ID: 5649335
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum creatine phosphokinase in various muscular diseases seen in the field of orthopedic surgery].
    Iwamoto A
    Igaku Kenkyu; 1969 May; 39(2):108-21. PubMed ID: 5389323
    [No Abstract]   [Full Text] [Related]  

  • 10. [The value and significance of changes of serum aldolase and creatine phosphokinase in muscular diseases].
    Corridori F; Lazzaroni M; Lombardi B
    Riv Neurobiol; 1968; 14(4):573-89. PubMed ID: 5738409
    [No Abstract]   [Full Text] [Related]  

  • 11. [The serum-creatine phosphokinase (CPK) activity in amyotrophic lateral sclerosis (ALS) and other neurogenous muscular atrophies with regard to differential diagnostic aspects].
    Koufen H; Consbruch U
    Nervenarzt; 1970 Dec; 41(12):599-603. PubMed ID: 4924032
    [No Abstract]   [Full Text] [Related]  

  • 12. Colchicine-induced myopathy with normal creatine phosphokinase level in a renal transplant patient.
    Caglar K; Safali M; Yavuz I; Odabaşi Z; Yenicesu M; Vural A
    Nephron; 2002 Dec; 92(4):922-4. PubMed ID: 12399640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Creatine phosphokinase isoenzymes in human muscle biopsies].
    Magalhaes AS
    Acta Neurol Belg; 1970; 70(4):471-81. PubMed ID: 4992101
    [No Abstract]   [Full Text] [Related]  

  • 14. Spinal muscular atrophy with autosomal dominant inheritance. Report of a new kindred.
    Zellweger H; Simpson J; McCormick WF; Ionasescu V
    Neurology; 1972 Sep; 22(9):957-63. PubMed ID: 4673381
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum creatine phosphokinase changes following needle electromyographic tudies.
    Cherington M; Lewin E; McCrimmon A
    Neurology; 1968 Mar; 18(3):271-2. PubMed ID: 5689668
    [No Abstract]   [Full Text] [Related]  

  • 16. An improved procedure for serum creatine phosphokinase determination.
    Rosalki SB
    J Lab Clin Med; 1967 Apr; 69(4):696-705. PubMed ID: 4381359
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of ACTH upon the serum CPK activity in various neuromuscular diseases].
    Araki S; Narazaki T; Kuroiwa Y
    Igaku To Seibutsugaku; 1967 Jan; 74(1):1-5. PubMed ID: 4292148
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum myoglobin in primary and secondary skeletal muscle disorders.
    Kiessling WR; Ricker K; Pflughaupt KW; Mertens HG; Haubitz I
    J Neurol; 1981; 224(3):229-33. PubMed ID: 6162019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A malignant form of neurogenic muscular atrophy in adults, with dominant inheritance.
    Zatz M; Penha-Serrano C; Frota-Pessoa O; Klein D
    J Genet Hum; 1971 Dec; 19(4):337-54. PubMed ID: 5152133
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of cortisol on serum creatine phosphokinase activity in disuse atrophy.
    Ahmad SB; Raina PN
    Naturwissenschaften; 1975 Jul; 62(7):353-4. PubMed ID: 1196399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.